Finished
TAP-patients With Robotic Assisted Lap Prostatectomy
NCT01582477 · Pacira Pharmaceuticals, Inc · Updated 14 June 2021
- What is being tested
- EXPAREL 20 mL; EXPAREL 40 mL
- For
- Postsurgical Pain; Analgesia; Prostatectomy
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 75 years. About 24 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started March 2012, ends July 2012. Registered 20 April 2012.
- Results
- Posted on the registry on 10 June 2013.
In the researchers' words
The purpose of the study is to assess the safety and efficacy of EXPAREL when administered via infiltration into the transversus abdominis plane (TAP) to prolonged postsurgical analgesia in men undergoing robot-assisted laparoscopic prostatectomy.
Sites
- Steward St. Elizabeth'sBrighton, Massachusetts, United States